What is the difference between Argireline and TB4-Frag?

Argireline: Inhibits SNARE complex formation in facial muscles; reduces acetylcholine release locally; relaxes expression lines without systemic effects TB4-Frag: Active fragment of Thymosin Beta-4; promotes actin dynamics and cell migration; activates hair follicle stem cells; modulates inflammatory signaling

Is Argireline FDA approved?

Argireline is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

Is TB4-Frag FDA approved?

TB4-Frag is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

How is Argireline administered in research settings?

In research settings, Argireline is typically administered via the topical route. PeptideBase does not provide dosing or administration instructions.

How is TB4-Frag administered in research settings?

In research settings, TB4-Frag is typically administered via the subcutaneous or topical routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Argireline vs TB4-Frag

Peptide Comparison

Argireline vs TB4-Frag

Both are Skin & Cosmetic peptides.

Argireline

Acetyl Hexapeptide-3

Skin & JointNot EvaluatedResearch Only

Half-life: N/A (topical)

18 providers listed

Full Argireline profile →

TB4-Frag

Thymosin Beta-4 Fragment

Skin & JointNot EvaluatedResearch Only

Half-life: Unknown

12 providers listed

Full TB4-Frag profile →

Bottom line

Argireline carries stronger published evidence (RCT, 3 key studies) than TB4-Frag (Animal, 2); both are research compounds.

Quick Verdict

Argireline

Evidence

Clinical

TB4-Frag

Evidence

Preclinical

Which One Should You Choose?

Your goal	Better option
Stronger clinical evidence	Argireline
More provider options (18 vs 12)	Argireline

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Argireline

TB4-Frag

Mechanism Family

Skin & Cosmetic

Half-life

N/A (topical)

Unknown

FDA Status

not evaluated

Admin Routes

topical

subcutaneous, topical

Availability

Research Only

Providers

18 listed

12 listed

Avail. Notes

Cosmetic peptide (acetyl hexapeptide-3). Sold as cosmetic ingredient by Lipotec/Sederma. Not regulated as a drug by FDA. No NDA or IND. Cosmetic anti-wrinkle ingredient only.

N-terminal TB-4 fragment (Ac-SDKP tetrapeptide). Distinct from full-length TB-500/Thymosin Beta-4 (Category 2). No separate FDA action on this fragment. Anti-fibrotic research use only.

Research Evidence

Argireline

ClinicalRCT · 3 key studies · most recent 2026

TB4-Frag

PreclinicalAnimal · 2 key studies · most recent 2016

Research Citations

Argireline

RCT2013 · American Journal of Clinical Dermatology

The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-…

Cohort2026 · Biomater Adv

DES-mediated self-assembled polypeptides: Synergistic neuromuscular signaling inhibition for anti-aging.

RCT2017 · Journal of Cosmetic Dermatology

The efficacy study of the combination of tripeptide-10-citrulline and acetyl hexapeptide-3: a prospective, ra…

TB4-Frag

Animal2016 · Molecular Genetics and Genomics

Role of thymosin beta 4 in hair growth

Animal2007 · Annals of the New York Academy of Sciences

Thymosin beta 4 induces hair growth via stem cell migration and differentiation

About Argireline

Inhibits SNARE complex formation in facial muscles; reduces acetylcholine release locally; relaxes expression lines without systemic effects

Research Areas

SNARE complex (SNAP-25) competitive inhibition reducing expression line depthwrinkle reduction documented in controlled human trialstopical cosmetic application — not a systemic peptidesoftening of dynamic lines over 4–8 weeks at 5–10% concentration

About TB4-Frag

Active fragment of Thymosin Beta-4; promotes actin dynamics and cell migration; activates hair follicle stem cells; modulates inflammatory signaling

Research Areas

hair growthwound healinganti-inflammatorytissue repair

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Argireline

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

TB4-Frag

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Find Providers

Where to source these peptides

Providers offering

Argireline

18 listed

Browse directory →

Providers offering

TB4-Frag

12 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Skin & Cosmetic Comparisons

Browse all peptides →

Educational research tools — not medical advice.